Studion announced it has promoted Brian Harrington to General Manager of its Life Sciences business unit, where he will lead strategy, growth, and delivery of the company’s end-to-end eClinical services. The move is aimed at helping life sciences organizations accelerate the development and delivery of new treatments.
Harrington brings significant experience in the clinical trials and digital health ecosystem. In his previous role in Commercial Development, he focused on customer success and operations, strengthening client relationships and helping shape new service offerings aligned with evolving market needs.
Studion’s Life Sciences unit provides platform-agnostic eClinical services, supporting clinical trials through solutions such as eCOA, eConsent, and electronic data capture. The company has worked on more than 2,000 implementations across a range of therapeutic areas, positioning it as a partner for organizations seeking compliant, patient-centered trial technologies.
The promotion comes as demand for scalable and efficient eClinical solutions continues to grow. Studion has also been expanding its managed services offerings for study start-up and maintenance, designed to improve operational predictability, reduce costs, and streamline trial execution.
KEY QUOTES:
“Brian’s understanding of the complexity of clinical trial technology and his ability to think creatively about how to solve it makes him the ideal leader for our Life Sciences business unit. This promotion reflects our continued commitment to being a trusted partner to our clients and a leader in eClinical tech services, including our new managed services offerings for study start-up and study maintenance.”
Furqan Nazeeri, CEO of Studion
“I’m honored to step into this role at such an exciting time for both Studion and the life sciences industry. As the eClinical landscape continues to evolve, our clients are looking for more strategic, scalable ways to deliver with confidence. While staff augmentation remains an important part of our business, I’m especially excited about the continued growth of our study start-up and maintenance managed service offerings. These offerings help eCOA and eClinical companies improve financial and operational predictability, reduce costs, and help bring life-changing therapies to patients faster.”
Brian Harrington, General Manager of Life Sciences Business Unit at Studion
